Skip to main content
    U

    USANA Health Sciences Inc (USNA)

    Official site

    CONSUMER DEFENSIVE • PACKAGED FOODS • NYSE

    $13.55
    +0.31 (+2.34%)

    Market Cap: $244.79M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    USANA Health Sciences Inc (USNA) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    USANA Health Sciences (USNA) trades at 13.2x trailing earnings and 0.3x sales. Its P/E of 13.2x is below its 5-year median of 14.2x. Its forward P/E is 10.6x. The median P/E across 6 similar companies is 11.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.5% higher over the next year. Its free cash flow yield is 11.8%.

    MultipleValue
    P/E (trailing)13.2x
    Forward P/E10.6x
    Price to sales0.3x
    Price to book0.5x
    EV/EBITDA2.1x
    Price to FCF8.5x
    EV/FCF2.4x
    PEG0.9
    FCF yield11.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 13.2% below 15.2x, its P/S is 78.6% below 1.4x and its P/B is 87.2% below 3.9x.

    MultipleCurrent5-year median10-year median
    P/E13.2x14.2x15.2x
    P/S0.3x1.0x1.4x
    P/B0.5x1.8x3.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 10.2x in 2025 to 23.0x in 2018. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$19.6310.2x0.4x0.7x
    2024$35.8913.8x0.8x1.3x
    2023$53.6016.2x1.1x2.1x
    2022$53.2014.8x1.0x2.4x
    2021$101.2017.7x1.7x5.0x
    2020$77.1013.2x1.4x3.7x
    2019$78.5517.8x1.7x4.9x
    2018$117.7323.0x2.4x7.4x
    2017$74.0518.7x1.7x4.9x
    2016$61.2015.3x1.5x4.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About USNA

    What is USNA's forward P/E ratio?

    USANA Health Sciences has a forward P/E ratio of 10.6x.

    Is USNA stock overvalued?

    GNG's valuation label for USNA is Undervalued. Its P/E of 13.2x compares with a median of 11.9x across 6 similar companies.

    What is USNA's price to sales ratio?

    USANA Health Sciences has a price to sales ratio of 0.3x.

    What is USANA Health Sciences's average P/E ratio over 5 years?

    USANA Health Sciences's median P/E over the last 5 years is 14.2x, from 60 month-end values through Oct 2026.

    What is USNA's PEG ratio?

    USANA Health Sciences has a PEG ratio of 0.9.